Keiichi Sumida

3.7k total citations
64 papers, 1.3k citations indexed

About

Keiichi Sumida is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Keiichi Sumida has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Nephrology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Keiichi Sumida's work include Dialysis and Renal Disease Management (26 papers), Chronic Kidney Disease and Diabetes (12 papers) and Potassium and Related Disorders (8 papers). Keiichi Sumida is often cited by papers focused on Dialysis and Renal Disease Management (26 papers), Chronic Kidney Disease and Diabetes (12 papers) and Potassium and Related Disorders (8 papers). Keiichi Sumida collaborates with scholars based in United States, Japan and Hungary. Keiichi Sumida's co-authors include Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Praveen K. Potukuchi, Miklos Z. Molnar, Kunihiro Yamagata, Fridtjof Thomas, Jun Lü, Elani Streja, Connie M. Rhee and Melissa Soohoo and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Kidney International.

In The Last Decade

Keiichi Sumida

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Sumida United States 20 516 280 219 206 201 64 1.3k
Lucia Di Micco Italy 17 726 1.4× 42 0.1× 304 1.4× 198 1.0× 208 1.0× 34 1.3k
Ibrahim F. Shatat United States 20 354 0.7× 37 0.1× 196 0.9× 95 0.5× 287 1.4× 43 1.2k
Rengin Elsürer Türkiye 17 287 0.6× 119 0.4× 75 0.3× 190 0.9× 41 0.2× 57 751
Marie Metzger France 24 786 1.5× 33 0.1× 215 1.0× 254 1.2× 149 0.7× 71 1.9k
Martha E. Lyon Canada 19 63 0.1× 163 0.6× 138 0.6× 201 1.0× 116 0.6× 60 950
Santo Morabito Italy 22 769 1.5× 29 0.1× 101 0.5× 237 1.2× 132 0.7× 74 1.3k
Alice Sabatino Italy 24 940 1.8× 55 0.2× 1.0k 4.8× 305 1.5× 277 1.4× 58 1.9k
Shailendra Sharma United States 14 245 0.5× 28 0.1× 129 0.6× 124 0.6× 209 1.0× 22 787
Shivam Joshi United States 19 333 0.6× 25 0.1× 562 2.6× 187 0.9× 160 0.8× 62 1.4k
António W. Gomes‐Neto Netherlands 18 191 0.4× 30 0.1× 277 1.3× 158 0.8× 119 0.6× 68 923

Countries citing papers authored by Keiichi Sumida

Since Specialization
Citations

This map shows the geographic impact of Keiichi Sumida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Sumida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Sumida more than expected).

Fields of papers citing papers by Keiichi Sumida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Sumida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Sumida. The network helps show where Keiichi Sumida may publish in the future.

Co-authorship network of co-authors of Keiichi Sumida

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Sumida. A scholar is included among the top collaborators of Keiichi Sumida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Sumida. Keiichi Sumida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sumida, Keiichi, Esther A. Obeng, & Csaba P. Kövesdy. (2025). Clonal Hematopoiesis in Kidney Disease. Clinical Journal of the American Society of Nephrology.
3.
Sumida, Keiichi, Prabin Shrestha, Fridtjof Thomas, et al.. (2024). Anti–Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease. JAMA Network Open. 7(4). e246822–e246822. 2 indexed citations
4.
Sumida, Keiichi, Prabin Shrestha, Fridtjof Thomas, et al.. (2024). Incident Diuretic Use and Subsequent Risk of Bone Fractures. Mayo Clinic Proceedings. 99(6). 913–926. 2 indexed citations
5.
Shrestha, Prabin, Keiichi Sumida, Fridtjof Thomas, et al.. (2023). Association of oral iron replacement therapy with kidney failure and mortality in CKD patients. Clinical Kidney Journal. 16(11). 2082–2090. 4 indexed citations
6.
Sumida, Keiichi, Annabel Biruete, Brandon M. Kistler, et al.. (2023). New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease. Journal of Renal Nutrition. 33(6). S6–S12. 13 indexed citations
7.
Potukuchi, Praveen K., Hamid Moradi, Frank Park, et al.. (2021). Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis. Cannabis and Cannabinoid Research. 8(1). 138–147. 5 indexed citations
8.
Sumida, Keiichi, Praveen K. Potukuchi, Yoshitsugu Obi, et al.. (2021). Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD. ˜The œNephron journals/Nephron journals. 145(3). 265–274. 5 indexed citations
9.
Sumida, Keiichi, Fridtjof Thomas, Justin Gatwood, et al.. (2021). Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis. American Journal of Nephrology. 52(7). 539–547. 1 indexed citations
10.
Sumida, Keiichi, Praveen K. Potukuchi, Fridtjof Thomas, et al.. (2021). Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis. Journal of the American Society of Nephrology. 32(4). 950–959. 20 indexed citations
11.
Yazawa, Masahiko, Orsolya Cseprekál, Ryan A. Helmick, et al.. (2020). Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol. ˜The œNephron journals/Nephron journals. 144(3). 126–137. 4 indexed citations
12.
Sumida, Keiichi, Praveen K. Potukuchi, Fridtjof Thomas, et al.. (2020). Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease. Journal of Renal Nutrition. 31(4). 361–369. 6 indexed citations
13.
Gosmanova, Elvira O., Miklos Z. Molnar, Adnan Naseer, et al.. (2020). Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality. The American Journal of Medicine. 133(9). 1065–1073.e3. 11 indexed citations
14.
Yazawa, Masahiko, Orsolya Cseprekál, Ryan A. Helmick, et al.. (2019). Association between post‐transplant donor‐specific antibodies and recipient outcomes in simultaneous liver–kidney transplant recipients: single‐center, cohort study. Transplant International. 33(2). 202–215. 10 indexed citations
15.
Gaipov, Abduzhappar, Miklos Z. Molnar, Praveen K. Potukuchi, et al.. (2018). Acute kidney injury following coronary revascularization procedures in patients with advanced CKD. Nephrology Dialysis Transplantation. 34(11). 1894–1901. 11 indexed citations
16.
Sumida, Keiichi, Miklos Z. Molnar, Praveen K. Potukuchi, et al.. (2018). Constipation and risk of death and cardiovascular events. Atherosclerosis. 281. 114–120. 171 indexed citations
17.
Sumida, Keiichi, Hiroki Mizuno, Toshiharu Ueno, et al.. (2018). Lupus nephritis with massive subendothelial deposits in a patient with autoimmune hepatitis-related cirrhosis. Human Pathology Case Reports. 13. 27–32. 1 indexed citations
18.
Molnar, Miklos Z., Keiichi Sumida, Abduzhappar Gaipov, et al.. (2017). Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients. Dementia and Geriatric Cognitive Disorders. 43(5-6). 281–293. 7 indexed citations
19.
Sumida, Keiichi, Miklos Z. Molnar, Praveen K. Potukuchi, et al.. (2017). Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease. ˜The œNephron journals/Nephron journals. 137(1). 15–22. 18 indexed citations
20.
Sumida, Keiichi, Miklos Z. Molnar, Praveen K. Potukuchi, et al.. (2017). Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients. ˜The œNephron journals/Nephron journals. 137(1). 57–63. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Di Micco Breakdown of academic impact, for papers by Ibrahim F. Shatat Breakdown of academic impact, for papers by Rengin Elsürer Breakdown of academic impact, for papers by Marie Metzger Breakdown of academic impact, for papers by Martha E. Lyon Breakdown of academic impact, for papers by Santo Morabito Breakdown of academic impact, for papers by Alice Sabatino Breakdown of academic impact, for papers by Shailendra Sharma Breakdown of academic impact, for papers by Shivam Joshi Breakdown of academic impact, for papers by António W. Gomes‐Neto
Rankless by CCL
2026